Title: Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance
Abstract: FPA Women's Health, Long Beach, California Financial Disclosure Dr. Steward is a consultant for Afaxys, Bayer, and Merck Pharmaceuticals.
Publication Year: 2017
Publication Date: 2017-04-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 3
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot